July 8, 2024
The Alliance of Community Health Plans (ACHP) submitted a comment letter to the United States Patent and Trademark Office (USPTO) on double patenting, or “patent thickets.” ACHP urges USPTO to make the proposed rule final to level the playing field and promote greater competition by addressing patent thickening, which will ultimately lower prescription drug costs for consumers.
New from ACHP:
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
- ACHP Letter to Dr. Oz on Deregulation in Health Insurance
- ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
- ACHP Statement on CY2026 MA and Part D Rate Notice
- ACHP Statement on Final CY2026 MA and Part D Rule
